Search

everythinglearnresearchcommunity

for

Search:↓

Low-intensity ultrasound can safely enhance hair regrowth by selecting the right frequency and intensity.

ILC1 cells contribute to hair loss in alopecia areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Intense pulsed-light therapy helps mice grow hair by activating a specific growth pathway.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The combination treatment showed a higher response rate but no significant survival benefits.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

PDGF isoforms can promote and sustain hair growth.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

PCFCL may have unrecognized subtypes and needs more research.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

Baricitinib may effectively treat oral lichen planus.

Patients need better information about the risks of long-term steroid use.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.